How Mounjaro Can Affect Your Period: Side Effects and Safety Guidance

Why significant weight loss reshapes your hormonal picture

The most widely reported reason for cycle changes on Mounjaro is the speed and scale of weight loss itself, rather than tirzepatide acting directly on reproductive tissue. Adipose (fat) tissue is hormonally active: it converts androgens into oestrogen through a process called aromatisation, so as fat stores reduce, circulating oestrogen levels can shift noticeably. The hypothalamic-pituitary-ovarian axis (the hormone chain that controls ovulation) is sensitive to rapid energy deficits, and the appetite suppression that makes Mounjaro effective can also create a temporary signalling disruption.

Clinical trial data from SURMOUNT-1, published in the New England Journal of Medicine, showed average weight reductions of around 20% over 72 weeks at the 15mg dose. Hormonal fluctuation at that scale of fat loss is well-documented in obesity medicine generally. It is also, in many cases, self-limiting: once weight stabilises at a lower level, many people find their cycle settles into a new regular pattern.

A common misconception worth addressing gently: some women assume period irregularity means Mounjaro is harming their fertility. The picture is more nuanced. Returning to a healthy body weight can actually restore ovulation in women whose cycles had been irregular because of excess weight. But unpredictable cycles also mean unpredictable fertility, which is why contraception remains essential. The full overview of Mounjaro on this site covers the licensed use and eligibility criteria if you want broader context.

The oral contraceptive interaction: what tirzepatide's mechanism means in practice

Tirzepatide slows gastric emptying as part of how it reduces appetite. That same mechanism can affect how quickly other oral medicines (including the combined or progestogen-only pill) move through the stomach and into the small intestine where absorption happens. The MHRA advises that women using oral contraceptives should add a barrier method such as condoms for the first four weeks of starting Mounjaro and for four weeks after every dose increase, because the pill's absorption may be reduced during those periods.

This advice is detailed in NHS England's guidance on weight-management injections, which also notes that no equivalent absorption concern has been identified for semaglutide. Switching to a non-oral method (an IUD, implant, patch or injection) removes the interaction concern entirely and is worth discussing with your GP or prescriber if you are on long-term Mounjaro treatment.

If your cycle changes coincide with a dose increase, it is worth keeping a note of dates and symptoms. That pattern can help your prescriber distinguish between an interaction-related disruption and a change driven by accelerating weight loss. Our prescribers discuss contraception and side effect expectations as part of the consultation process, you can start your free consultation here to go through your specific situation.

When to get medical help, and what to report

Most menstrual changes on Mounjaro are a nuisance rather than a danger, and many settle within a few cycles. There are symptoms, though, where you should contact a doctor promptly rather than waiting to see what happens next. Seek medical attention if you experience: very heavy bleeding (soaking through a pad or tampon in an hour or less, repeatedly); a period that has stopped entirely for three months or more without a known cause; severe pelvic pain that is new or worsening; or any bleeding after the menopause.

You should also seek urgent help for symptoms that are unrelated to your cycle but can occur with tirzepatide, in particular, severe persistent stomach pain that spreads to your back, with or without vomiting. This symptom pattern can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but serious risk associated with GLP-1 medicines. If you want a fuller picture of the 5 Mounjaro side effects most important to recognise, our dedicated page sets out what to watch for and when to act.

If you believe your menstrual change is linked to Mounjaro, you can report it directly to the MHRA using the Yellow Card scheme. Patient reports through Yellow Card contribute to ongoing post-market safety monitoring and help regulators identify patterns that clinical trials may have been too short to capture. It is free, takes a few minutes, and you do not need a doctor's referral to submit one.

Planning ahead: fertility, pregnancy and stopping treatment

Because cycle changes can make ovulation unpredictable, reliable contraception is important throughout Mounjaro treatment and for a wash-out period afterwards. Tirzepatide is not recommended in pregnancy, during breastfeeding, or for anyone actively trying to conceive. If you are planning a pregnancy, your prescriber will advise on stopping treatment and the appropriate gap before trying, and our page on what side effects to expect if you are taking Mounjaro can help you understand how your body may respond during and after that transition.

For women experiencing mood changes alongside cycle disruption, it is worth knowing these two things can reinforce each other, fluctuating oestrogen affects neurotransmitter signalling. The Mounjaro and mood side effects page covers what is known about that connection. If you are finding the side effect picture complex to navigate, the FAQs section addresses common questions, and our support team is available seven days a week. For those who have experienced fewer side effects than expected, our page on Mounjaro and no side effects explains what that typically means.